Illumina (ILMN) - Stock Price & Dividends

Illumina, Inc. is a company that focuses on providing advanced sequencing- and array-based solutions for genetic and genomic analysis. These solutions are utilized not only in the United States but also in countries like Singapore and the United Kingdom. The company operates through two main segments - Core Illumina and GRAIL.

Customers can rely on Illumina for a range of products including sequencing and array-based instruments, consumables like reagents and flow cells, whole-genome sequencing kits, and targeted resequencing kits. Additionally, Illumina offers services such as whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services, along with an innovative multi-cancer early detection test called Galleri.

Furthermore, Illumina is dedicated to developing solutions that aim to expedite cancer diagnoses, enhance blood-based detection for minimal residual disease, and pioneer various post-diagnostic applications. The company caters to a broad customer base including genomic research centers, academic institutions, government laboratories, hospitals, pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies.

Established in 1998 and headquartered in San Diego, California, Illumina, Inc. actively collaborates with industry partners such as Myriad Genetics to expand access to HRD testing. To learn more about Illumina and its offerings, visit their website at https://www.illumina.com.